Non-alcoholic fatty liver disease and cardiovascular disease; from epidemiology to clinical and nutrition management: A narrative review Maria Partsafa, Demosthenes Panagiotakos
Diagnostic methods and pharmacological management of non-alcoholic fatty liver disease – There is still room for improvement Chrysoula Boutari, Panagiotis Pappas, Konstantinos Tziomalos, Vasileios Athyros, Asterios Karagiannis
Is non-alcoholic steatohepatitis in lean people a risk factor for liver or cardiovascular disease? Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas, Georgios Sfikas, Charalambos Koumaras, Niki Katsiki, Vasilios Athyros
Evaluation of Different Scores to Predict Non-alcoholic Fatty Liver Disease in patients with type 2 diabetes Angeliki M Angelidi, Athanasia Papazafiropoulou, Eleni-Margarita Tzouganatou, Konstantina Anagnostopoulou, Vasilis Velissaris, Vangelis Markakis, Ekaterini Vagena, Αndreas Melidonis
Hypolipidemic, Hepatoprotective and Anti-inflammatory Role of Chios Mastic gum in Streptozotocin-induced Diabetic Mice with Fatty Liver Disease Aspasia Tzani, Evanthia Bletsa, Ilias P Doulamis, Laskarina-Maria Korou, Panagiotis Konstantopoulos, Ioannis S Vlachos, Ioannis Georgiadis, Despina N Perrea